Streamlined structure aimed at further increasing profitability
22 Oct 2009 - VITA 34 International AG has decided to restructure its management team after successfully returning to the black. This move is to lay the foundations for further increasing profitability in the coming years.
Dr. Eberhard Lampeter, founder and CEO of VITA 34 AG, will continue to head the company. Finance will be headed by Jörg Ulbrich in the future. Mr. Ulbrich was in charge of Administration at VITA 34 up to now and therefore has an in-depth insight into the company.
The previous CFO, Peter Boehnert, has requested to leave the company from October 31, 2009. He is now looking for a new challenge elsewhere. He leaves on good terms after successfully implementing cost reduction measures which were launched in mid 2008. The VITA 34 International AG Supervisory Board agreed to his request.
Oliver Papavlassopoulos has also announced that he will be stepping down from his position as Chief Marketing Officer on October 31, 2009. He is planning to work on a self-employed basis in the future. In the last few years, he has been highly successful in paving the way for VITA 34's internationalization. The new appointments in this area of the company represent a careful realignment of Marketing and Sales, and these measures are to create a better benefit-cost ratio. The overall aim is to support further earnings increases in the coming years.
http://www.bionity.com/news/e/108335/
Don't worry about the mule going blind just load the wagon.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM